Patent · US Active

Methods for treating renal disease

US10130632B2 · kind B2 · utility

1Cited by
11References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 20, 2013
Grant dateNov 20, 2018
Priority date
Expiry dateNov 20, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/531
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention features methods for treating or reducing the likelihood of developing a renal disease by administering to a subject in need thereof an agent that decreases expression of a pathogenic APOL1. The agents of the method target various signaling pathways and decrease the level of the pathogenic APOL1 polypeptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.